Legal & General Group
KITE

Legal & General Group’s Kite Pharma, Inc. KITE Stock Holding History

Legal & General Group’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-21,252
Closed -$3.82M – 3322
2017
Q3 		$3.82M Buy
21,252
+3,288
+18% +$458K ﹤0.01% 1204
2017
Q2 		$1.87M Buy
17,964
+3,386
+23% +$276K ﹤0.01% 1566
2017
Q1 		$1.15M Buy
14,578
+1,080
+8% +$66.8K ﹤0.01% 1742
2016
Q4 		$607K Buy
13,498
+4,326
+47% +$212K ﹤0.01% 1925
2016
Q3 		$511K Buy
9,172
+149
+2% +$8.3K ﹤0.01% 1685
2016
Q2 		$450K Buy
9,023
+1,261
+16% +$62K ﹤0.01% 1380
2016
Q1 		$355K Buy
7,762
+1,134
+17% +$54.9K ﹤0.01% 1483
2015
Q4 		$414K Buy
6,628
+313
+5% +$22K ﹤0.01% 1386
2015
Q3 		$353K Buy
6,315
+1,812
+40% +$114K ﹤0.01% 1408
2015
Q2 		$284K Buy
4,503
+3,094
+220% +$177K ﹤0.01% 1561
2015
Q1 		$84K Hold
1,409
– – ﹤0.01% 2157
2014
Q4 		$79K Buy
+1,409
New +$59.3K ﹤0.01% 2149

Legal & General Group's KITE Position: Q4 2017 in Review

Legal & General Group sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 21,252 shares — an estimated $3.82M sold.

Legal & General Group first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $3.82M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Legal & General Group reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Legal & General Group sold 21,252 Kite Pharma, Inc. shares in Q4 2017, an estimated $3.82M.
  • Legal & General Group first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • Legal & General Group's Kite Pharma, Inc. position peaked at $3.82M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Legal & General Group's 13F filing for Q4 2017, filed 13 Feb 2018.